Markets:

Overview

News

Currencies

International

Treasuries

Fate Therapeutics, Inc. - Common Stock (NQ:FATE)

1.170 +0.080 (+7.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Fate Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Analyst Ratings for Fate Therapeutics ↗

September 07, 2023

Via Benzinga

The Latest Analyst Ratings for Fate Therapeutics ↗

August 16, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 01, 2023

On Tuesday, 46 stocks hit new 52-week lows.

Via Benzinga

Why Shares of Fate Therapeutics Soared This Week ↗

June 16, 2023

The company's shares bounced back after a stock sale last week.

Via The Motley Fool

Where Fate Therapeutics Stands With Analysts ↗

May 05, 2023

Via Benzinga

Fate Therapeutics: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

Fate Therapeutics Earnings Preview ↗

May 02, 2023

Via Benzinga

15 Analysts Have This to Say About Fate Therapeutics ↗

March 27, 2023

Via Benzinga

$1.7M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

April 24, 2023

Although US stocks closed slightly higher on Friday, there were a few notable insider trades.

Via Benzinga

Expert Ratings for Fate Therapeutics ↗

March 01, 2023

Via Benzinga

Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

February 14, 2023

Don’t forget to check out our premarket coverage here Fate Therapeutics, Inc. (NASDAQ: FATE) fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday,...

Via Benzinga

Sorrento Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

February 13, 2023

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

5 Cheapest Health Care Stocks You Should Think About ↗

January 27, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Analyst Ratings for Fate Therapeutics ↗

January 24, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023 ↗

January 24, 2023

Via Benzinga

5 Health Care Stocks That Are Diving - And May Rally ↗

January 19, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Over $10 Million Bet On DiamondHead Holdings? Check Out These 4 Stocks Insiders Are Buying ↗

January 17, 2023

Although US stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

Top 5 Health Care Stocks That May Surge ↗

January 10, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

How Is The Market Feeling About Fate Therapeutics? ↗

January 09, 2023

Fate Therapeutics's (NASDAQ:FATE) short percent of float has fallen 4.62% since its last report. The company recently reported that it has 20.24 million shares sold short, which is 27.85% of all...

Via Benzinga

CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC ↗

January 06, 2023

Gene-editing stocks have not been immune when it comes to job losses and workforce reductions. Here are a few of the latest.

Via InvestorPlace

Dow Jumps 700 Points; S&P 500 Rises Over 2% ↗

January 06, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 06, 2023

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge ↗

January 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 06, 2023

During Friday's trading, 71 companies set new 52-week lows.

Via Benzinga

Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday ↗

January 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Is Fate Therapeutics (FATE) Stock Down 62% Today? ↗

January 06, 2023

Fate Therapeutics (FATE) stock is falling on Friday after the company announced the termination of its collaboration with Janssen Biotech.

Via InvestorPlace

Tesla Falls Again, but This Nasdaq Stock Is Truly Plunging ↗

January 06, 2023

The Nasdaq Composite once again is underperforming the rest of the market.

Via The Motley Fool

Fate Therapeutics Ends Collaboration Deal With Janssen, Cuts Staff ↗

January 06, 2023

Via Benzinga

Dow Rises Over 300 Points; US Adds 223,000 Jobs In December ↗

January 06, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Fate Therapeutics, Inc. - Common Stock (NQ:FATE)

Headline News about Fate Therapeutics, Inc. - Common Stock